Bristol’s Opdivo + Yervoy Gets FDA Liver, Colorectal Cancer Nods

 
• By Joseph Haas
  
Gold "FDA approved" label
BMS's Opdivo + Yervoy combo picks up two more US indications (Shutterstock)

More from Strategy

More from R&D